AI: The End of Manual Study Build

Date:

Event Overview

This webinar explores how this technological leap is fundamentally redefining the role of the CDM and moving past the era of the “day-to-day builder” and entering the era of the strategic quality steward. This session will provide a deep dive into how AI-powered workflows are reshaping the way studies are designed, reviewed and launched, setting a new industry benchmark for trial readiness.

Whether you are looking to slash build-to-launch timelines or seeking to elevate your team’s impact, this session will move beyond the AI hype to provide a practical roadmap for implementation. The session will discuss the measurable value this transformation brings to sponsors, CROs and sites, from airtight standardization to radical efficiency gains.

Key Learning Objectives

  • How AI agents are solving the technical complexity of modern study builds and eliminating manual bottlenecks.
  • Why strategic oversight and governance is the new standard for the modern data manager.
  • How AI-driven builds reduce rework, boost compliance and raise expectations across the global clinical landscape.
  • Practical strategies for implementation, from establishing new governance models to managing the human side of digital transformation.

Who Should Attend:

This webinar is designed for leaders and practitioners who are navigating the evolution of clinical trial EDC study build. It is particularly relevant for:

  • Heads and Directors of: Clinical Operations, Data Management, Clinical Programming, Data Science, and Clinical IT.
  • Strategic Leads: CIOs, CTOs, and Heads of Clinical Analytics.
  • Study Builders & Data Managers: Professionals currently managing manual builds who are ready to transition into the role of strategic quality stewards.
  • Operational Managers: Senior Managers and above responsible for clinical operations, data management, and digital transformation.

Whether you are overseeing a global portfolio or are on the front lines of study building and data management, this session provides the roadmap to move from manual execution to AI-driven oversight.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

Accelerating early RWE exploration without increasing analytic burden

How can lean life sciences teams generate credible real-world...

The Data Readiness Index: Understanding the Foundations for Successful AI

As AI tools and data-driven strategies reshape the competitive...

Validating HealthVerity eXOs: An agentic AI platform for real-world evidence

Can you trust AI to generate real-world evidence? This...

The RWE Backlog Problem

Emerging pharma teams face growing pressure to answer critical...